{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:09:22Z","timestamp":1794672562878,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.eclinm.2021.100988","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T09:57:10Z","timestamp":1624874230000},"page":"100988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"special_numbering":"C","title":["High cerebrospinal amyloid-\u03b2 42 is associated with normal cognition in individuals with brain amyloidosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Andrea","family":"Sturchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok K.","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-2137","authenticated-orcid":false,"given":"Christina B.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-6672","authenticated-orcid":false,"given":"Abhimanyu","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir EL","family":"Andaloussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L.","family":"Poston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5802-5487","authenticated-orcid":false,"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-0675","authenticated-orcid":false,"given":"Kariem","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J.","family":"Espay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.100988_bib0001","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.eclinm.2021.100988_bib0002","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fnins.2020.00256","article-title":"Disentangling the amyloid pathways: a mechanistic approach to etiology","volume":"14","author":"Malmberg","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.eclinm.2021.100988_bib0003","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjmed.2013.10.029","article-title":"Insulin-derived amyloidosis and poor glycemic control: a case series","volume":"127","author":"Nagase","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.eclinm.2021.100988_bib0004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/acs.biochem.9b00796","article-title":"Prion-like p53 amyloids in cancer","volume":"59","author":"Navalkar","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.eclinm.2021.100988_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and A\u03b2: implications for Alzheimer's disease pathology and therapeutics","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0006","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","article-title":"Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease","volume":"91","author":"McDade","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2021.100988_bib0007","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","article-title":"Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease","volume":"2","author":"Ch\u00e9telat","year":"2013","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.eclinm.2021.100988_bib0008","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.38.11.1682","article-title":"Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease","volume":"38","author":"Crystal","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2021.100988_bib0009","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.56.12.1690","article-title":"Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study","volume":"56","author":"Polvikoski","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2021.100988_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.25410","article-title":"Amyloid-\u03b2 immunotherapy for alzheimer disease: is it now a long shot?","volume":"85","author":"Panza","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0011","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.eclinm.2021.100988_bib0012","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","article-title":"Prevalence of biologically vs clinically defined alzheimer spectrum entities using the national institute on aging-Alzheimer's association research framework","volume":"76","author":"Jack","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0013","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0014","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awu367","article-title":"Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer's disease","volume":"138","author":"Mattsson","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.eclinm.2021.100988_bib0015","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.eclinm.2021.100988_bib0016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/WNL.0000000000002081","article-title":"Use of amyloid PET-to determine cutpoints for CSF markers: a multicenter study","volume":"86","author":"Zwan","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2021.100988_bib0017","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.eclinm.2021.100988_bib0018","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","article-title":"A composite score for executive functioning, validated in Alzheimer's disease neuroimaging initiative (ADNI) participants with baseline mild cognitive impairment","volume":"6","author":"Gibbons","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.eclinm.2021.100988_bib0019","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/sim.7263","article-title":"Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method","volume":"36","author":"Dwivedi","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.eclinm.2021.100988_bib0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116802","article-title":"Cerebrospinal fluid \u03b2-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease\u2013systematic review and meta-analysis","volume":"10","author":"Mo","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2021.100988_bib0022","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1523\/JNEUROSCI.0974-04.2004","article-title":"Neurogenic effect of beta-amyloid peptide in the development of neural stem cells","volume":"24","author":"L\u00f3pez-Toledano","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.eclinm.2021.100988_bib0023","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.22313","article-title":"Endogenous amyloid-\u03b2 is necessary for hippocampal synaptic plasticity and memory","volume":"69","author":"Puzzo","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0024","first-page":"403","article-title":"Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: a prospective 9-year study","volume":"1","author":"Stomrud","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.eclinm.2021.100988_bib0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.100988_bib0026","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0027","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12017-014-8302-1","article-title":"Altered cerebrospinal fluid levels of amyloid \u03b2 and amyloid precursor-like protein 1 peptides in Down's syndrome","volume":"16","author":"Portelius","year":"2014","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.eclinm.2021.100988_bib0028","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.21623","article-title":"A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system","volume":"66","author":"Bateman","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2021.100988_bib0029","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.100988_bib0030","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-210415","article-title":"Soluble amyloid-\u03b2 consumption in Alzheimer's disease","volume":"82","author":"Espay","year":"2021","journal-title":"J Alzheimers Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:06:22Z","timestamp":1762887982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"alternative-id":["S2589537021002686"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.100988","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High cerebrospinal amyloid-\u03b2 42 is associated with normal cognition in individuals with brain amyloidosis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.100988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100988"}}